Original Research
Product naming, pricing, and market uptake of biosimilars
Author(s): 1 Joseph P Fuhr, PhD, 2 Amitabh Chandra, PhD, 3 John Romley, PhD, 4 Tiffany Shih, PhD, 5 Suepattra G May, MPH, PhD, Jacqueline Vanderpuye-Orgle, MSc, PhD
Page: 64-71
Abstract: With a number of patents on biological medicines soon to expire in the US, multiple stakeholders – from policymakers to manufacturers to payers – have been debating the structure… Read More »
Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance
Author(s): Brian Godman, BSc, PhD, Hye-Young Kwon, BPharm, MPH, PhD, Ljiljana Sović Brkičić, MPharm, Martina Bogut, BSc, Miron Sršen, MD, Tonko Tabain, MD, Winnie de Bruyn, BSc
Page: 79-89
Author byline as per print journal: Ljiljana Sović Brkičić, MPharm; Brian Godman, BSc, PhD; Martina Bogut, BSc; Miron Sršen, MD; Hye-Young Kwon, BPharm, MPH, PhD; Winnie de Bruyn, BSc; Tonko Tabain,… Read More »
Differences in pharmacokinetic behaviour of branded enoxaparin and a US generic version in a non-human primate model
Author(s): 1 Professor Walter P Jeske, PhD, Debra Hoppensteadt, PhD, Jawed Fareed, PhD, Jeanine M Walenga, PhD, Josephine Cunanan, MD, Mamdouh Bakhos, MD, Nicolas Simon, MD, PhD, Vicki Escalante, BS
Page: 72-8
Author byline as per print journal: Professor Walter P Jeske, PhD; Jeanine M Walenga, PhD; Nicolas Simon, MD, PhD; Debra Hoppensteadt, PhD; Josephine Cunanan, MD; Vicki Escalante, BS; Jawed Fareed, PhD;… Read More »
Payer and physician evidence and discount requirements for biosimilars in three Latin American countries
Author(s): 1 Erik Sandorff, MA, MBA, André Vidal Pinheiro, PhD, Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc, Daniele Severi Bruni, MPhil, Ronald Halbert, MD, MPH
Page: 11-6
Study objectives: In Latin America, many governments have attempted to address biosimilar safety and efficacy concerns by developing abbreviated regulatory pathways to increase access while controlling quality. This study explores… Read More »
What pricing and reimbursement policies to use for off-patent biologicals? – Results from the EBE 2014 biological medicines policy survey
Author(s): European Biopharmaceutical Enterprises
Page: 17-24
Objective: One of the questions that the advent of biosimilars raises is whether the different nature of biological medicines would also imply the need for a different policy approach by… Read More »
Availability and procurement conditions of originator and generic medicines in hospitals – an exploratory study in five medium-sized European countries
Author(s): 1 Sabine Vogler, PhD, 2 Nina Zimmermann, MA, 3 Jan Mazag, PharmaDr
Page: 168-79
Aim: To explore whether medicines used in hospitals in European countries are supplied as originators or generic medicines, and to investigate the procurement conditions, including the extent of discounts at… Read More »
Ongoing initiatives to improve prescribing efficiency in China; statins as a case history
Author(s): Alexander E Finlayson, MD, MRCP, Brian Godman, BSc, PhD, Houmei Xi, B Eng, Rickard E Malmstrom, MD, PhD, Wenjie Zeng, BSc, PhD
Page: 122-32
Author byline as per print journal: Wenjie Zeng, BSc, PhD; Houmei Xi, B Eng; Brian Godman, BSc, PhD; Alexander E Finlayson, MD, MRCP; Rickard E Malmstrom, MD, PhD Introduction: Pharmaceutical expenditure… Read More »
Barriers to market uptake of biosimilars in the US
Author(s): Abigail E Felix, BA, Anumeha Gupta, MD, Joshua P Cohen, PhD, Kim Riggs, MPH
Page: 108-15
Author byline as per print journal: Joshua P Cohen, PhD; Abigail E Felix, BA; Kim Riggs, MPH; Anumeha Gupta, MD Background: In the US, a new approval pathway for biosimilars has been established… Read More »
GnRH agonists and antagonists in prostate cancer
Author(s): Frans Erdkamp, MD, PhD, Niels Boone, PharmD, Robert Janknegt, PharmD, PhD, Victor Zambon, MD
Page: 133-42
Author byline as per print journal: Robert Janknegt, PharmD, PhD, Niels Boone, PharmD, Frans Erdkamp, MD, PhD, Victor Zambon, MD Abstract: This manuscript describes the System of Objectified Judgement Analysis… Read More »
Retrospective chart review: disrupted anaemia control in haemodialysis patients following the switch to an iron sucrose similar (ISS) after long-term treatment with the originator iron sucrose (IS)
Author(s): Alessandra Moglia, PhD, Corinne Emery, MSc, Jacques Rottembourg, MD
Page: 116-21
Author byline as per print journal: Professor Jacques Rottembourg, MD; Corinne Emery, MSc; Alessandra Moglia, PhD Study objective: To describe and compare the haematological parameters and the anaemia medication use in… Read More »